Can a Platelet-Boosting drug speed recovery in kids with neuroblastoma?
NCT ID NCT06818916
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests whether hetrombopag, a drug that stimulates platelet production, can help children with neuroblastoma recover their platelets faster after a stem cell transplant. Thirty children will take the drug daily for up to 6 weeks. The main goal is to see if it increases the rate of platelet engraftment, which could reduce the need for platelet transfusions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hetrombopag (a drug that stimulates platelet production)
- What this could lead to
- If it works, this could offer a way to speed up platelet recovery after stem cell transplant, reducing the need for transfusions in children with neuroblastoma.
- What could go wrong
- This is a small, early-phase trial with only 30 children, so results may not apply broadly. The drug may not improve platelet engraftment or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Stem Cell Transplantation, Beijing Children's Hospital, Capital Medical University
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a shorter chemo combo tame High-Risk neuroblastoma?
- Can a radioactive 'Smart Bomb' take down resistant childhood cancers?
- Can AI read tumor slides to outsmart childhood cancer?
- Can a radioated molecule shrink untreatable neuroblastoma?
- Slowing down immunotherapy infusion may reduce pain in children with Tough-to-Treat neuroblastoma